Narlaprevir
In Stock•Starting at $529 for 2 mg
| CAS No. | 865466-24-6 |
|---|---|
| MDL No. | N/A |
| MF | C36H61N5O7S |
| MW | 708.00 |
| InChI Key | RICZEKWVNZFTNZ-LFGITCQGSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 2 mg | To Be Confirmed | $529 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Narlaprevir is an azabicyclohexane, specifically (1R,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane, substituted at positions 2S and 3 with [(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]aminoacyl and N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl groups, respectively. It is a hepatitis C virus (HCV) NS3/4A serine protease inhibitor (Ki = 6 nM) used in the treatment of chronic hepatitis C. It functions as a hepatitis C protease inhibitor, antiviral drug, EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor, and anticoronaviral agent. It is classified as a sulfone, urea, tertiary carboxamide, azabicyclohexane, pyrrolidinecarboxamide, secondary carboxamide, and member of cyclopropanes.
| CAS No. | 865466-24-6 |
|---|---|
| Product Name | Narlaprevir |
Associated Conditions
hepatitis C virus infection·chronic hepatitis C virus infection·viral disease·liver disease
* The information provided here is compiled from public sources and is for reference only.
